文献速递临床试验与 GCP流行病学与生物统计

连接点滴:整合标准化自闭症谱系障碍筛查、高质量治疗与长期结局的整群随机临床试验

Connecting the Dots: a cluster-randomized clinical trial integrating standardized autism spectrum disorders screening, high-quality treatment, and long-term outcomes.
PubMed 文献 · Trials · 2021-05-02

本研究为在美国3个中心开展的整群随机对照试验,计划纳入3450名儿童,比较儿科诊所实施普遍标准化高保真幼儿自闭症筛查与常规照护对5岁时结局的影响。两组确诊自闭症儿童均接受 Early Start Denver Model 干预1年,每周最多20小时。主要结局为自闭症症状严重度和认知功能。

要点

  • 评估普遍标准化高保真筛查能否改善自闭症儿童5岁时结局。
  • 确诊儿童均接受 Early Start Denver Model 干预,每周最多20小时,持续1年。
  • 主要结局为 BOSCC 测量的症状严重度及 MSEL/DAS-II 测量的认知功能。

核心结论

  • 该试验旨在评估普遍标准化高保真自闭症筛查对儿童5岁时结局的影响,以支持尽早检测自闭症并启动治疗。

研究设计与样本

  • 整群随机对照临床试验,在美国3个中心开展,儿科诊所按规模分层随机。
  • 计划纳入3450名儿童,每组约一半,预计100名儿童确诊自闭症。

主要发现

  • 原文未报告试验结果,仅描述设计与结局指标。

关键数值与推荐

  • 主要结局在基线、治疗后及4岁和5岁时测量,包括 BOSCC 和 MSEL/DAS-II。
  • 次要结局包括适应功能、自闭症症状、幼儿园准备度及父母压力和赋权。
  • 治疗为 Early Start Denver Model,持续1年,每周最多20小时。

临床怎么用

  • 原文未报告临床实践推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Autism spectrum disorder (ASD) affects one in 54 children in the United States of America, and supporting people with ASD across the lifespan presents challenges that impact individuals, families, and communities and can be quite costly. The American Academy of Pediatrics has issued recommendations for routine ASD screening at 18 and 24 months, but some research suggests that few pediatricians perform high-fidelity, standardized screening universally. Furthermore, the United States Preventive Services Task Force (USPSTF) found insufficient evidence to recommend for or against universal ASD screening. The objective of this study is to test the hypothesis that children with ASD who have high fidelity; standardized screening will achieve superior outcomes at 5 years of age compared to children receiving usual care ASD detection strategies. METHODS: This is a cluster-randomized, controlled clinical trial in 3 sites in the USA. Pediatric practices will be randomized to implement universal, standardized, high-fidelity toddler screening or usual care, with randomization stratified by the practice size. The study will enroll 3450 children, approximately half in each group. From this sample, we anticipate 100 children to be diagnosed with ASD. Children in both groups receiving an ASD diagnosis will be administered the Early Start Denver Model, an evidence-based early intervention addressing social, communication, and cognitive functioning. Treatment will last for 1 year, with up to 20 h per week of therapy for children with ASD. RESULTS: Primary outcomes measured at baseline, following treatment, and at 4 and 5 years of age include ASD symptom severity (Brief Observation of Social Communication Change (BOSCC)) and cognitive functioning (Mullen Scales of Early Learning (MSEL) and Differential Abilities Scale-II (DAS-II)). Secondary outcomes in children include measures of adaptive functioning, ASD symptoms, and kindergarten readiness; secondary analyses will also examine stress and empowerment among parents. Several novel exploratory measures will be included as well. The study will utilize a modified intention-to-treat analysis. CONCLUSIONS: This trial will evaluate the impact of universal, standardized, high-fidelity screening for ASD among children at 18 months of age, with a goal of providing evidence to support this strategy to detect ASD in toddlers in order to start treatment as young as possible and maximize outcomes. ETHICS AND DISSEMINATION: This study was approved by the Institutional Review Board at Drexel University (IRB protocol: 1607004653). All findings will be provided by the principal investigator via email; data will be available through the NIMH Data Archive ( https://nda.nih.gov/ ). TRIAL REGISTRATION: ClinicalTrials.gov NCT03333629 . Registered on November 7, 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. McClure LA, Lee NL, Sand K, et al. Connecting the Dots: a cluster-randomized clinical trial integrating standardized autism spectrum disorders screening, high-quality treatment, and long-term outcomes. Trials. 2021. PMID: 33934719. doi:10.1186/s13063-021-05286-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。